BIONTECH SE ($BNTX) posted quarterly earnings results for Q3 2026 on Tuesday, November 3rd. The company reported earnings of $1.82 per share, beating estimates of $0.80 by $1.01. The company also reported revenue of $1,326,940,784, beating estimates of $1,075,685,512 by $251,255,272.
You can see Quiver Quantitative's $BNTX stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
BIONTECH SE Insider Trading Activity
BIONTECH SE insiders have traded $BNTX stock on the open market 22 times in the past 6 months. Of those trades, 0 have been purchases and 22 have been sales.
Here’s a breakdown of recent trading of $BNTX stock by insiders over the last 6 months:
- UGUR SAHIN (Chief Executive Officer) has made 0 purchases and 22 sales selling 706,209 shares for an estimated $69,312,250.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
BIONTECH SE Hedge Fund Activity
We have seen 143 institutional investors add shares of BIONTECH SE stock to their portfolio, and 107 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FLOSSBACH VON STORCH SE removed 2,052,866 shares (-92.2%) from their portfolio in Q3 2026, for an estimated $201,796,727
- FMR LLC added 1,862,565 shares (+32.6%) to their portfolio in Q2 2026, for an estimated $173,311,673
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,021,242 shares (-33.1%) from their portfolio in Q2 2026, for an estimated $95,026,568
- LOGOS GLOBAL MANAGEMENT LP added 1,015,000 shares (+inf%) to their portfolio in Q2 2026, for an estimated $94,445,750
- BAILLIE GIFFORD & CO removed 652,487 shares (-52.4%) from their portfolio in Q2 2026, for an estimated $60,713,915
- GOLDMAN SACHS GROUP INC added 493,074 shares (+509.2%) to their portfolio in Q2 2026, for an estimated $45,880,535
- DAVERN CAPITAL PARTNERS, LP added 449,495 shares (+147.3%) to their portfolio in Q2 2026, for an estimated $41,825,509
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
BIONTECH SE Price Targets
Multiple analysts have issued price targets for $BNTX recently. We have seen 3 analysts offer price targets for $BNTX in the last 6 months, with a median target of $119.0.
Here are some recent targets:
- Terence Flynn from Morgan Stanley set a target price of $119.0 on 07/08/2026
- David Dai from UBS set a target price of $135.0 on 05/27/2026
- Jeffrey Walch from Bernstein set a target price of $96.0 on 05/22/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
